89Bio Inc expected to post a loss of 41 cents a share - Earnings Preview

89bio

07/08/2023 19:35

* 89Bio Inc  ETNB.OQ   ETNB.O  is expected to show no change
in
quarterly revenue when it reports  results on August 9
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for 89Bio Inc is for a
loss
of 41 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for 89Bio Inc
is
$35​, above​ its last closing price of $16.25. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.48       -0.52      -0.54     Missed  -3.5
 Dec. 31 2023  -0.68       -0.69      -0.48     Beat    30.1
 Sep. 30 2022  -0.82       -0.80      -0.57     Beat    28.5​
 Jun. 30 2022  -1.04       -1.05      -1.23     Missed  -16.8
 ​​Mar.        -1.32       -1.29      -1.26     Beat    2.5
 31 2022                                                
 Dec. 31 2021  -1.49       -1.31      -1.30     Beat    0.6​
 Sep. 30 2021  -1.06       -1.06      -1.41     Missed  -33.5
 Jun. 30 2021  -0.82       -0.84      -1.03     Missed  -22.8
 This summary was machine generated August 7 at 18:35 GMT.  All
figures in US dollars  unless otherwise stated